“ipo” Archives

Entry Author Date Location
Five Takeaways from “What’s Hot in Boston Biotech” 04/11/16 Boston
What’s Ahead for Biotech in 2016: Q&A With BIO Chair Ron Cohen 03/31/16 New York
Invitae Scales Up DNA Test Offerings, Scores Mild Market Bump 03/29/16 San Francisco
Restructuring Looms for Forum as Neuro Drug Fails Key Clinical Test 03/24/16 Boston
Post NexGen Purchase, Austin Software Firm Pivot3 Raises $55M 03/15/16 Texas
Blueprint, Roche Ink Milestone Deal for Cancer Immunotherapy 03/15/16 Boston
Austin Virtual Reality Startup Virtuix Targets “Mini-IPO” Funding 03/10/16 Texas
Ensemble Quietly Amasses Cancer Drug Pipeline, Scouts for New Deals 03/08/16 Boston
East Coast Biotech Roundup: Ribon, Syndax, Aldeyra & More 03/03/16 Boston
FAST Act Offers More Goodies to Emerging Growth Companies 03/02/16 Boston
With Eye Drug Data, Aldeyra Takes a Small Step Forward in Inflammation 02/29/16 Boston
East Coast Biotech Roundup: Scangos, CRISPR, Yumanity, Synlogic & More 02/11/16 New York
Thinking IPO? ThinkingPhones Dials Up $112M, Adopts the Name Fuze 02/09/16 Boston
CRISPR Hits Wall Street as Editas Bags $94M in IPO 02/02/16 Boston
Seeking A Fresh Start in Gene Therapy, Avalanche Merges With Annapurna 02/01/16 San Francisco
East Coast Biotech Roundup: Editas, Hep C, Akashi, Tarveda & More 01/29/16 Boston
As Markets and Controversies Swirl, Editas Aims For $100M CRISPR IPO 01/25/16 Boston
From California to New York, Fintech Finds Loans for Almost Anyone 01/20/16 National
Eyeing First Trials, Syros Brings in $40M and More Crossovers 01/13/16 Boston
East Coast Bio Roundup: NY Startups, Editas, Bonney, C4 & (Much) More 01/08/16 Boston
Flash Sale: Web Retailer Gilt Groupe Sells to Hudson Bay for $250M 01/07/16 New York
Ever Fond of Options, Atlas Finds Potential Buyers For Rodin, Quartet 01/06/16 Boston
Eight Things You Might Not Have Known Until Editas Filed Its S-1 01/04/16 Boston
Scholar Rock Rolls Up $36M To Move Muscle Drug To Clinical Trials 01/04/16 Boston
Texas 2015: Bio IPOs, Mark Cuban, Dell, & Startups in Wine, Aviation 12/31/15 Texas
Innovation vs. Healthcare Spending: Biotech’s Biggest Looming Challenge 12/28/15 National
Acacia Aims to Go Public as Disappointing Year For Tech IPOs Closes 12/22/15 Boston
Months After Postponed IPO, Gelesis Nabs $31.5M And a New Investor 12/18/15 Boston
London Notebook: Conversations Inside The Biomedical Golden Triangle 12/15/15 National
East Coast Biotech Roundup: ASH, Kallyope, SQZ, Kyras & More 12/11/15 Boston
Page 3 of 21 « previous page · next page »